NCT03212859 is a NA clinical trial of Coach2Move in Sedentary Lifestyle, sponsored by Radboud University Medical Center.

Who is sponsoring NCT03212859?

NCT03212859 is sponsored by Radboud University Medical Center.

What drugs are being tested in NCT03212859?

Interventions in NCT03212859: Coach2Move, Usual Care.

What condition does NCT03212859 study?

NCT03212859 studies Sedentary Lifestyle, Physical Activity, Frail Elderly Syndrome.

Is NCT03212859 still recruiting?

NCT03212859 is currently completed. Last updated 17 March 2021.

Last reviewed 2021-03-17 · How we verify

NCT03212859

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Coach2Move: Sustainable in Daily Practice

Completed NA Last updated 17 March 2021

What this trial tests

NA trial testing Coach2Move in Sedentary Lifestyle in 292 participants. Completed in 4 September 2020.

Timeline

6 November 2017

Primary endpoint
4 September 2020

4 September 2020

Quick facts

Lead sponsor	Radboud University Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	292
Start date	6 November 2017
Primary completion	4 September 2020
Estimated completion	4 September 2020
Sites	1 location across Netherlands

Drugs / interventions tested

Coach2Move
Usual Care

Conditions studied

Sedentary Lifestyle — all drugs for Sedentary Lifestyle →
Physical Activity — all drugs for Physical Activity →
Frail Elderly Syndrome — all drugs for Frail Elderly Syndrome →

Sponsor

Radboud University Medical Center

Who can join

70 and older, any sex, with Sedentary Lifestyle or Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Implementation of a previously shown (cost-)effective physical therapeutic treatment strategy for community-dwelling older adults.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Implementing a Personalized Physical Therapy Approach (Coach2Move) Is Effective in Increasing Physical Activity and Improving Functional Mobility in Older Adults: A Cluster-Randomized, Stepped Wedge Trial.
Heij W, Sweerts L, Staal JB, Teerenstra S, et al · · 2022 · cited 7× · PMID 36200397 · DOI 10.1093/ptj/pzac138
Implementation of a Cost-Effective Physical Therapy Approach (Coach2Move) to Improve Physical Activity in Community-Dwelling Older Adults With Mobility Problems: Protocol for a Cluster-Randomized, Stepped Wedge Trial.
Heij W, Teerenstra S, Sweerts L, Staal JB, et al · · 2020 · cited 7× · PMID 31846501 · DOI 10.1093/ptj/pzz183
Implementing the Effective Coach2Move Approach for Community-Dwelling Older Adults With Mobility Limitations in Physical Therapist Practice: A Multi-Methods Process Evaluation.
Heij W, Sweerts L, Staal JB, van der Wees PJ, et al · · 2024 · cited 1× · PMID 39014297 · DOI 10.1093/ptj/pzae093

Verify or expand the search:

Other recruiting trials for Sedentary Lifestyle

Currently open trials in the same condition.

NCT03511352 — Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging · NA · active not recruiting
NCT03356262 — The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort · active not recruiting

Other Radboud University Medical Center trials

Trials by the same sponsor.

NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03212859 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
Last refreshed: 17 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03212859.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing